US Patent 10646480 Formulations of pimavanserin

US Patent 11840515 Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c

US Patent 10981870 Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form

US Patent 10981871 Methods for preparing N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form C

US Patent 11464768 Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis

US Patent 10849891 Formulations of pimavanserin

US Patent 10953000 Combination of pimavanserin and cytochrome P450 modulators